Yang Pan

P.R. China
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A prognostic nomogram for oligometastatic non-small cell lung cancer incorporating extent of primary tumor resection as a key predictor.

A prognostic nomogram for oligometastatic non-small cell lung cancer incorporating extent of primary tumor resection as a key predictor.

Journal: Journal of thoracic disease

Published: December 18, 2025

Pathologic response and nodal status guide adjuvant immunotherapy in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study.

Pathologic response and nodal status guide adjuvant immunotherapy in non-small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study.

Journal: The Journal of thoracic and cardiovascular surgery

Published: December 18, 2025

Lower r-FEV1 as a predictor of treatment response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy.

Lower r-FEV1 as a predictor of treatment response and survival in NSCLC patients receiving neoadjuvant immunochemotherapy.

Journal: Journal of thoracic disease

Published: March 07, 2025

Prognosis and distant metastasis patterns of early-onset gastric cancer compared with late-onset: a large-scale, cross-population retrospective study.

Prognosis and distant metastasis patterns of early-onset gastric cancer compared with late-onset: a large-scale, cross-population retrospective study.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: February 10, 2025

Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years.

Distinct clinical features and epidemiological trends of very early and middle-aged early onset colorectal cancer based on SEER 17 and GBD 2021 data over the past 15 years.

Journal: BMC cancer

Published: February 03, 2025

Lobectomy versus sub-lobar resection for special type non-small cell lung cancer ≤2 cm.

Lobectomy versus sub-lobar resection for special type non-small cell lung cancer ≤2 cm.

Journal: Journal of thoracic disease

Published: January 24, 2025

Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in NSCLC? A propensity score matching analysis.

Is adjuvant immunotherapy necessary after neoadjuvant chemoimmunotherapy in NSCLC? A propensity score matching analysis.

Journal: Journal of translational medicine

Published: September 16, 2024

Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients.

Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients.

Journal: Translational lung cancer research

Published: August 14, 2024

A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLC.

A real world analysis of secondary BRAF variations after targeted therapy resistance in driver gene positive NSCLC.

Journal: Scientific reports

Published: June 21, 2024

Author Correction: Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.

Author Correction: Developing a prognostic model using machine learning for disulfidptosis related lncRNA in lung adenocarcinoma.

Journal: Scientific reports

Published: June 14, 2024

Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pathologic N classification system.

Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pathologic N classification system.

Journal: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

Published: March 17, 2024

Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents.

Optimizing first-line TKI treatment efficacy in PD-L1-positive EGFR-mutated NSCLC: the impact of antiangiogenic agents.

Journal: Frontiers in pharmacology

Published: February 26, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026